233 related articles for article (PubMed ID: 15451796)
1. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
Johnstone MT; Perez AS; Nasser I; Stewart R; Vaidya A; Al Ammary F; Schmidt B; Horowitz G; Dolgoff J; Hamilton J; Quist WC
Circulation; 2004 Oct; 110(14):2060-5. PubMed ID: 15451796
[TBL] [Abstract][Full Text] [Related]
2. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of rupture of atherosclerotic plaque by Candesartan in rabbit model].
Zhou XF; Yin HC; Zhu WL; Shen L; Yu T; Li SA; Meng ZM; Wu AS; Qian HD
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):106-11. PubMed ID: 20388376
[TBL] [Abstract][Full Text] [Related]
4. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Candido R; Allen TJ; Lassila M; Cao Z; Thallas V; Cooper ME; Jandeleit-Dahm KA
Circulation; 2004 Mar; 109(12):1536-42. PubMed ID: 15023892
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
Takai S; Jin D; Sakaguchi M; Muramatsu M; Ishii K; Kirimura K; Sakonjo H; Miyazaki M
Hypertens Res; 2004 Jul; 27(7):517-22. PubMed ID: 15302989
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
Hope S; Brecher P; Chobanian AV
Am J Hypertens; 1999 Jan; 12(1 Pt 1):28-34. PubMed ID: 10075381
[TBL] [Abstract][Full Text] [Related]
7. Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartan.
Hadi NR; Yousif NG; Abdulzahra MS; Mohammad BI; Al-Amran FG; Majeed ML; Yousif MG
Cardiovasc Ther; 2013 Dec; 31(6):381-7. PubMed ID: 23566285
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits.
Ichikawa N; Toma N; Kawakita F; Matsushima S; Imanaka-Yoshida K; Yoshida T; Taki W; Suzuki HI
Neurol Res; 2015 Feb; 37(2):147-52. PubMed ID: 25089806
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
10. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Abela GS; Picon PD; Friedl SE; Gebara OC; Miyamoto A; Federman M; Tofler GH; Muller JE
Circulation; 1995 Feb; 91(3):776-84. PubMed ID: 7828306
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
[TBL] [Abstract][Full Text] [Related]
12. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
13. [The effect of captopril and valsartan on preventing the formation of atherosclerotic plaque].
Lu YS; Lei XY; DI J; Huang ST; Li JM
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):425-7. PubMed ID: 16008853
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.
Arishiro K; Hoshiga M; Negoro N; Jin D; Takai S; Miyazaki M; Ishihara T; Hanafusa T
J Am Coll Cardiol; 2007 Apr; 49(13):1482-9. PubMed ID: 17397679
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.
Poon M; Gertz SD; Fallon JT; Wiegman P; Berman JW; Sarembock IJ; Taubman MB
Atherosclerosis; 2001 Apr; 155(2):371-80. PubMed ID: 11254907
[TBL] [Abstract][Full Text] [Related]
17. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
Li J; Hirose N; Kawamura M; Arai Y
Atherosclerosis; 1999 Apr; 143(2):315-26. PubMed ID: 10217360
[TBL] [Abstract][Full Text] [Related]
18. Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat.
Zezina L; Larsson E; Fellström B
Transpl Immunol; 2001 Feb; 8(4):245-51. PubMed ID: 11316067
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.
Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B
Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis.
Nagy N; Melchior-Becker A; Fischer JW
Basic Res Cardiol; 2010 Jan; 105(1):29-38. PubMed ID: 19701787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
